Tag: AACR
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
By Kara Nyberg, PhD
Posted: June 24, 2020
New findings from the TRACERx lung study underscore the value of using circulating tumor DNA (ctDNA) to predict...
PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC
By Kara Nyberg, PhD
Posted: June 24, 2020
The phase II PASSION trial sought to explore the potential synergy between immunotherapy and antiangiogenic drug therapy previously...
Prior Pneumonitis as a Risk Factor for Treatment-Associated Pneumonitis With Immune...
By Kara Nyberg, PhD
Posted: June 24, 2020
Pneumonitis is a well-known complication associated with immune checkpoint inhibitors (ICI). A collaborative effort between the U.S. Food...
Single-Agent Pembrolizumab Active Against STK11– and KEAP1– Mutated NSCLC According to...
By Kara Nyberg, PhD
Posted: June 24, 2020
Genomic alterations in STK11 and KEAP1 represent two of the most common and potent contributors to a cold...
TERAVOLT: Global Registry Investigates Outcomes Among Patients With Thoracic Cancer and...
By Marina Chiara Garassino, MD, and Leora Horn, MD, MSc, FRCPC
Posted: June 9, 2020
The new SARS-CoV-2 (COVID-19) virus appeared at the end of December...
Key Findings from the CAR T-Cell Study Presented at the 2019...
By Prasad S. Adusumilli, MD, FACS, FCCP
Posted: November 12, 2019
My colleagues and I conducted a phase I clinical trial of mesothelin-targeted chimeric antigen receptor...
